The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation.

SET-CAN/NUP214 fusion acute T lymphoblastic leukemia acute myeloid leukemia allogeneic stem cell transplanation del(9q)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 10 07 2023
accepted: 25 09 2023
medline: 30 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: epublish

Résumé

SET-NUP214 fusion gene, also known as TAF-1-CAN and SET-CAN, is observed in acute myeloid leukemia (AML) and T-cell lymphoblastic leukemia (T-ALL). SET-NUP214 fusion in T-cell lymphoblastic leukemia is associated with chemotherapy resistance, but the prognosis of patients with AML with SET-NUP214 has rarely been reported. In the present study, we retrospectively analyzed all patients with acute leukemia including AML and T-ALL patients with SET-NUP214 fusion who underwent allogeneic stem cell transplantation (alloHSCT) in our center from July 2017 to November 2022. Of the total 11 patients, 5 patients were diagnosed with AML and 6 patients were diagnosed with T-ALL

Identifiants

pubmed: 37901324
doi: 10.3389/fonc.2023.1256043
pmc: PMC10611484
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1256043

Informations de copyright

Copyright © 2023 Shen, Yang, Zhang, Chen, Ma, Wei, Zhai, Pang, He, Jiang and Feng.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell. 2001 Jan 12;104(1):119-30
pubmed: 11163245
Blood. 2014 Mar 20;123(12):1860-3
pubmed: 24449214
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Bone Marrow Transplant. 2023 Oct;58(10):1163-1166
pubmed: 37474728
Ann Clin Lab Sci. 2011 Summer;41(3):267-72
pubmed: 22075511
Ann Hematol. 2012 Feb;91(2):193-201
pubmed: 21720744
Onco Targets Ther. 2020 Aug 03;13:7665-7681
pubmed: 32821125
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Apr;31(2):352-357
pubmed: 37096505
Biol Blood Marrow Transplant. 2020 Feb;26(2):285-291
pubmed: 31494229
Blood. 2008 May 1;111(9):4668-80
pubmed: 18299449
Leuk Lymphoma. 2016 Feb;57(2):451-452
pubmed: 25956045
Cell Rep. 2023 Aug 29;42(8):112884
pubmed: 37516964
Genes Chromosomes Cancer. 1992 Oct;5(3):227-34
pubmed: 1384675
J Hematol Oncol. 2009 Jan 23;2:3
pubmed: 19166587
Semin Cell Dev Biol. 2009 Jul;20(5):620-30
pubmed: 19577736
Br J Haematol. 2023 Jul;202(2):369-378
pubmed: 37157187

Auteurs

Yuyan Shen (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Donglin Yang (D)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Rongli Zhang (R)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Xin Chen (X)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Qiaoling Ma (Q)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Jialin Wei (J)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Weihua Zhai (W)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Aiming Pang (A)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Yi He (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Erlie Jiang (E)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Sizhou Feng (S)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Tianjin Institutes of Health Science, Tianjin, China.

Classifications MeSH